D
Knight Therapeutics Inc. KHTRF
$4.72 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -542.81% 145.15% 142.89% -99.13% -203.61%
Total Depreciation and Amortization -8.84% -13.50% 19.85% -3.88% 6.34%
Total Amortization of Deferred Charges -- -- 2.25% -- --
Total Other Non-Cash Items 2,111.75% -81.72% -142.00% 381.59% 91.38%
Change in Net Operating Assets 207.65% -169.83% -324.29% -49.41% -5.12%
Cash from Operations 1,944.21% -88.84% -92.04% -67.48% 28.25%
Capital Expenditure 10.88% 61.41% -23.42% -62.06% -327.55%
Sale of Property, Plant, and Equipment -- -51.40% -94.95% -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -50.61% 229.71% 631.59% -67.47% 180.19%
Cash from Investing -952.38% 223.86% 1,022.76% -68.30% 174.72%
Total Debt Issued 14,544.44% 231.93% -- -39.47% -48.23%
Total Debt Repaid -606.28% -3.72% 34.14% 9.37% -34.47%
Issuance of Common Stock 6.76% 54.05% 47.37% 409.09% 223.81%
Repurchase of Common Stock 99.52% -- 73.01% 74.84% 91.10%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 7.19% 37.13% 36.70% 40.82% 13.47%
Cash from Financing 542.29% -52.37% 58.20% 65.64% 49.52%
Foreign Exchange rate Adjustments -204.85% 96.13% 112.76% 399.38% -229.96%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -1,574.59% 639.00% 133.08% -67.82% 89.16%